Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, and Steering Committee Member at Lung Cancer Policy Network, shared a post on LinkedIn:
“Led by Prof. Brigette B.Y. Ma our Chief Medical Director, we were pleased to have welcomed regional and local colleagues from Amgen Oncology, Greater Bay Area International Clinical Trial Institute (GBAICTI) OASES of the HKSAR to visit our CUHK Medicine Phase1 Clinical Trial Centre.
Lots of discussions and plans on how we can synergise and help propel the Greater Bay Area into a dynamic and influential drug development hub for the region and globally.”
More posts featuring Herbert Loong.